Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wilson disease patients sought for survey to shape gene editing research

NCT ID NCT07226622

Ongoing Knowledge-focused Sponsor: Prime Medicine, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study surveys 30 adults with Wilson disease to learn about their daily management, treatment adherence, and interest in gene editing clinical trials. By gathering this information, researchers hope to design better future studies for potential gene therapies targeting specific ATP7B mutations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help design better future clinical trials for gene editing treatments in Wilson disease.
What could go wrong
This is a small, observational prescreening study with only 30 participants, so it won't directly test any treatment or provide health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WILSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Congenital, Hereditary, and Neonatal Diseases and Abnormalities hereditary disease inborn errors of metabolism inborn metal metabolism disorder liver disorder metabolic disease Nutritional and Metabolic Diseases Wilson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WILSON DISEASE

Contacts and locations

Locations

  • American Research Corporation

    San Antonio, Texas, 78215, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • University of California Davis Health

    Sacramento, California, 95817, United States

  • University of California Los Angeles Medical Center

    Los Angeles, California, 90027, United States

  • University of Michigan Medicine

    Ann Arbor, Michigan, 48109, United States

  • Yale New Haven Hospital

    New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.